Abstract
During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept™ PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.
Original language | English |
---|---|
Pages (from-to) | 142-144 |
Number of pages | 3 |
Journal | Journal of Invasive Cardiology |
Volume | 19 |
Issue number | 3 |
Publication status | Published - Mar 2007 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine